» Articles » PMID: 396790

Histopathology of CNS Leukemia and Complications of Therapy

Overview
Specialty Pediatrics
Date 1979 Jan 1
PMID 396790
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

An understanding of the pathology of central nervous system (CNS) leukemia has evolved slowly. Observations in the 19th century clearly established CNS leukemia as a disease involving the leptomeninges. Although infiltration of the leptomeninges by leukemic cells remains the principal CNS lesion in patients with this disease, other histopathologic changes have become evident with the development of antileukemic therapy. During the early years of chemotherapy, as patient survival increased, the effects of chronic meningeal leukemia, e.g., increased intracranial pressure, became prominent. Only recently, following effective control of CNS leukemia with chemotherapy and irradiation, did it become clear that current methods of treatment can produce neurotoxic effects. Two specific examples are leukoencephalopathy and mineralizing microangiopathy, both apparently induced by the effects of radiation on the microvasculature. Only through careful prospective studies can the consequences and actual incidence of these two lesions be determined. These results will permit sounder judgments of whether the risks of CNS radiotherapy outweigh the known benefits.

Citing Articles

Digital PCR-based quantification of miR-181a in the cerebrospinal fluid aids patient stratification in pediatric acute lymphoblastic leukemia.

Peterffy B, Nadasi T, Krizsan S, Horvath A, Mark A, Barna G Sci Rep. 2024; 14(1):28556.

PMID: 39558071 PMC: 11574027. DOI: 10.1038/s41598-024-79733-0.


Routes and molecular mechanisms of central nervous system involvement in acute myeloid leukemia (Review).

Chen L, Zeng P, Tang H, Chen G, Xie J, Yang X Oncol Rep. 2024; 52(5).

PMID: 39219268 PMC: 11378150. DOI: 10.3892/or.2024.8805.


CXCR4 antagonists disrupt leukaemia-meningeal cell adhesion and attenuate chemoresistance.

Jonart L, Ostergaard J, Brooks A, Fitzpatrick G, Chen L, Gordon P Br J Haematol. 2022; 201(3):459-469.

PMID: 36535585 PMC: 10121760. DOI: 10.1111/bjh.18607.


Central nervous system involvement in childhood acute lymphoblastic leukemia: challenges and solutions.

Thastrup M, Duguid A, Mirian C, Schmiegelow K, Halsey C Leukemia. 2022; 36(12):2751-2768.

PMID: 36266325 PMC: 9712093. DOI: 10.1038/s41375-022-01714-x.


Targeted blockade of immune mechanisms inhibit B precursor acute lymphoblastic leukemia cell invasion of the central nervous system.

Rajakumar S, Grandal I, Minden M, Hitzler J, Guidos C, Danska J Cell Rep Med. 2022; 2(12):100470.

PMID: 35028611 PMC: 8714910. DOI: 10.1016/j.xcrm.2021.100470.